Proteomics International Laboratories Limited reported earnings results for the full year ended June 30, 2022. For the full year, the company reported net loss was AUD 4.97 million compared to AUD 2.86 million a year ago. Basic loss per share from continuing operations was AUD 0.05 compared to AUD 0.03 a year ago.
Proteomics International Laboratories Ltd
Equities
PIQ
AU000000PIQ0
Biotechnology & Medical Research
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.03 AUD | -1.44% | +0.49% | +15.08% |
May. 16 | Proteomics International Laboratories Supports Root Rot Study with Biomarker Platform | MT |
Mar. 25 | Proteomics International Signs Agreement with University of Oxford for Endometriosis Study | MT |
EPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+15.08% | 90.12M | |
+9.42% | 115B | |
+11.84% | 106B | |
-1.05% | 21.96B | |
-14.15% | 21.87B | |
-5.29% | 19.21B | |
-4.16% | 18.08B | |
-38.29% | 17.71B | |
+7.99% | 14.32B | |
+36.24% | 12.42B |
- Stock Market
- Equities
- PIQ Stock
- News Proteomics International Laboratories Ltd
- Proteomics International Laboratories Limited Reports Earnings Results for the Full Year Ended June 30, 2022